BA
VYGR icon

BlackRock Advisors’s Voyager Therapeutics VYGR Stock Holding History

BlackRock Advisors’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$77K Sell
6,010
-140
-2% -$1.8K ﹤0.01% 3134
2016
Q3 		$74K Buy
6,150
+679
+12% +$9.19K ﹤0.01% 3141
2016
Q2 		$60K Buy
5,471
+3,512
+179% +$43K ﹤0.01% 3177
2016
Q1 		$17K Hold
1,959
– – ﹤0.01% 3469
2015
Q4 		$43K Buy
+1,959
New +$45.1K ﹤0.01% 3254

Other funds holding VYGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock Advisors's VYGR Position: Q4 2016 in Review

BlackRock Advisors reduced its Voyager Therapeutics (VYGR) stake by 2.3% in Q4 2016, selling an estimated $1.8K and leaving 6,010 shares worth $77K. The position accounts for ﹤0.01% of the portfolio, ranked #3134.

BlackRock Advisors first reported a position in VYGR in Q4 2015 and has held it in 5 quarters since. 56 funds tracked by Wall St. Rank hold VYGR as of Q4 2016.

  • BlackRock Advisors held 6,010 shares of Voyager Therapeutics worth $77K as of Q4 2016.
  • BlackRock Advisors sold 140 Voyager Therapeutics shares in Q4 2016, an estimated $1.8K.
  • Voyager Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3134 holding.
  • BlackRock Advisors first reported a position in Voyager Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • 56 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.